Magaldrate (INN) is a widely used antacid drug employed in the treatment of duodenal and gastric ulcers, as well as esophagitis caused by gastroesophageal reflux. Magaldrate has a variable composition corresponding approximately to Al₅Mg₁₀(OH)₃₁(SO₄)₂.xH₂O.
It contains Mg(OH)₂ content between 49.2% and 66.6%, Al(OH)₃ content between 32.1% and 45.9%, SO₄ content between 16.0% and 21.0%, and assay values ranging from 90% to 105% on dried basis.
We specialize in manufacturing high-purity antacid and pharmaceutical raw materials conforming to global pharmacopeia standards including IP, BP and USP.
| Physical State | White or almost white crystalline powder |
|---|---|
| Solubility | Practically insoluble in water and ethanol (96%); soluble in dilute mineral acids |
| pH | 8.0 – 10.5 (5% aqueous solution) |
Magaldrate is a highly effective antacid widely used in pharmaceutical formulations for the treatment of hyperacidity, acid indigestion, heartburn, gastritis, and gastroesophageal reflux disorders. It provides rapid and sustained acid-neutralizing action while maintaining an optimal gastric pH.
Magaldrate is effective in treating acid indigestion, heartburn, sour stomach and gas. It neutralizes stomach acid and gradually increases the pH level of the stomach, providing fast and long-lasting relief.
Some mild side effects may include intestinal pain, constipation and diarrhea.
Serious side effects requiring medical attention may include loss of appetite, tarry stools, slow reflexes, vomiting and skin rashes.
Expiry: 5 years from the date of manufacture.
Store protected from moisture in a cool and dry place.